BDBM767420 4-[[4-fluoro-3-[4-[4-[2-(2- methoxyethyl)-3-oxo-1-(2- pyridyl)pyrazolo[3,4-d]pyrimidin-6- yl]amino]phenyl]piperazine-1- carbonyl]phenyl]methyl]-2H- phthalazin-1-one::US20250270212, Compound 9

SMILES COCCn1c(=O)c2cnc(Nc3ccc(N4CCN(C(=O)c5cc(Cc6n[nH]c(=O)c7ccccc67)ccc5F)CC4)cc3)nc2n1-c1ccccn1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 767420   

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767420(4-[[4-fluoro-3-[4-[4-[2-(2- methoxyethyl)-3-oxo-1-...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent